Bluetti Black Friday Sale: Unmissable Deals on Innovative Power Solutions
With Black Friday just around the corner, Bluetti, a global leader in green energy storage—is gearing up for one of its ...
Frontiers2d
Understanding Adverse Effect in Myeloma Patients treated with T Cell Redirecting Immunotherapies
Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...
FierceBiotech3d
BMS' CAR-T cracks down on lupus, achieving sustained responses in phase 1
Bristol Myers Squibb has linked its CD19-directed CAR-T cell therapy to sustained clinical responses in people with systemic ...
The Business Journals5d
St. Louis cancer-drug startup names new medical chief
In addition to developing WU-CART-007, a drug candidate in clinical trials for treating relapsed or refractory T-cell acute ...